Americas (WHO region) vs Equatorial Guinea: Hepatitis B surface antigen (HBsAg) prevalence (%)
Americas (WHO region)
0.0%
in 2024
Equatorial Guinea
2.0%
in 2024
Americas (WHO region) rank
12th
Equatorial Guinea rank
12th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Americas (WHO region)
- Equatorial Guinea
How they compare
Equatorial Guinea currently reports 2.0% against 0.0% in Americas (WHO region), a difference of 2.0%.
Across all 10 years both countries report, Equatorial Guinea has been ahead every year.
Americas (WHO region) ranks 12th and Equatorial Guinea ranks 12th of 13 groups.
Equatorial Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Equatorial Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 2.3% | 2.3% | Equatorial Guinea |
| 2020s | 0.0% | 2.1% | 2.1% | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Americas (WHO region) or Equatorial Guinea?
- Equatorial Guinea, at 2.0% against 0.0% in Americas (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Americas (WHO region) and Equatorial Guinea?
- 2.0%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Americas (WHO region) and Equatorial Guinea?
- 10 years are reported by both, from 2015 to 2024.
- How do Americas (WHO region) and Equatorial Guinea rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Americas (WHO region) ranks 12th and Equatorial Guinea ranks 12th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.